Chronic pain remains an enigmatic and formidable challenge in medical science, affecting nearly one-fifth of the adult population globally and standing as a primary source of long-term disability. Differing significantly from acute pain, which arises predictably from injury or tissue damage, chronic pain frequently manifests spontaneously, with no identifiable external trigger. This unpredictability, coupled with pain intensity fluctuations occurring over minutes, hours, and days, complicates clinical assessment and management. Traditionally, clinicians have depended on self-reported pain scales, subjective and often inconsistent, revealing a profound need for objective biomarkers akin to measures like blood pressure or body temperature that could transform pain diagnosis and treatment.
In a groundbreaking study led by Associate Director WOO Choong-Wan at the Center for Neuroscience Imaging Research within the Institute for Basic Science, the scientific community has witnessed a pioneering advance in the search for a robust, individualized biomarker for chronic pain. Collaborating with Professor CHO Sungkun’s team at Chungnam National University, the researchers have harnessed the potential of personalized brain imaging combined with machine learning to decode the complex fluctuations of spontaneous pain in fibromyalgia patients—a group typified by diffuse and relentless pain without clear external cause.
Fibromyalgia, characterized by widespread spontaneous pain, was chosen as the model condition for this intensive longitudinal investigation. Over an extended period exceeding six months, participants underwent repeated functional magnetic resonance imaging (fMRI) sessions, a technique that measures cerebral blood oxygen level-dependent signals and thus offers insight into dynamic neural activity. During scanning, patients continuously reported their subjective pain levels, enabling the researchers to amass a rich, densely sampled dataset linking real-time brain function with fluctuating pain experience.
The crux of this study lies in applying advanced machine learning algorithms to these extended fMRI datasets. Unlike prior studies focusing on discrete brain regions, this research leveraged whole-brain functional connectivity, mapping the interactions among distributed neural networks implicated in pain processing. Such comprehensive mapping allowed the creation of individualized brain decoding models capable of predicting moment-to-moment pain intensity with remarkable precision across multiple temporal scales—from swift minute-level changes within single sessions to broader variations spanning days and weeks.
Interestingly, the study illuminated a critical insight: the neural signatures of chronic pain are highly individualized. The models trained on one participant’s brain data failed to generalize to others, underscoring the distinct neurobiological underpinnings shaping each person’s pain experience. This finding dismantles the long-held hope for universal brain-based pain markers and accentuates the necessity of precision neuroimaging tailored to the individual’s unique pain connectome, a concept describing the personalized pattern of brain connectivity that sustains their chronic pain.
One of the methodological breakthroughs revealed by this work is the paramount importance of extensive within-person data sampling. Traditional neuroimaging studies often rely on limited datasets, insufficient to capture the nuanced and fluctuating nature of spontaneous pain. Including ample longitudinal data markedly enhanced prediction accuracy, indicating that only through rich, repeated brain imaging coupled with continuous pain reporting can reliable personalized biomarkers be constructed—a revelation with profound implications for both scientific research and clinical practice.
This precision neuroimaging protocol sets a new standard, moving away from generalization toward bespoke pain profiling. The dense longitudinal approach provides a powerful tool to track the spontaneous and ephemeral nature of chronic pain and opens avenues toward objective, real-time pain assessment, a dramatic shift from subjective questioning toward quantifiable brain-derived metrics. Future extensions of this research may lead to non-invasive diagnostics and personalized therapeutic monitoring, transforming chronic pain care by enabling targeted interventions tuned to each patient’s unique neural pain architecture.
Moreover, these findings prompt reevaluation of the neurological complexity of chronic pain. That brain connectivity patterns differ so widely among individuals provokes questions about underlying biological variability—possible genetic, neurochemical, or environmental contributors—that dictate distinct pain processing pathways. Establishing such mechanistic insights is essential to classify chronic pain subtypes, which could refine diagnosis and optimize individualized treatment regimens in the emerging era of precision medicine.
Despite its promise, this research acknowledges limitations that warrant attention. The sample size was modest, and participants were exclusively fibromyalgia patients, prohibiting immediate clinical application. Nevertheless, the study provides a powerful methodological framework that invites replication and extension across broader, heterogeneous cohorts to determine if shared neural features exist among different chronic pain syndromes or if each case demands a uniquely tailored solution based on idiosyncratic brain network patterns.
Technically, the employment of whole-brain fMRI functional connectivity matrices in conjunction with machine learning represents a sophisticated integration of neuroimaging and computational modeling. The models capture complex, non-linear interactions across brain regions, demonstrating superior temporal resolution in decoding pain fluctuations compared to conventional region-of-interest analyses. This holistic analytic strategy could revolutionize how brain imaging data is interpreted beyond pain research, offering insights into other spontaneous subjective phenomena currently inaccessible to objective measurement.
At the forefront of this innovation is Dr. WOO Choong-Wan, who emphasizes the transformative potential of seeing the “invisible” pain. By translating neural signatures into objective pain estimates, this approach may alleviate an essential clinical dilemma: validating and quantifying the otherwise intangible suffering of chronic pain patients. Additionally, LEE Jae-Joong, lead author, highlights that personalized neural signatures could tailor pain management strategies, reducing trial-and-error approaches and enhancing efficacy.
This study’s publication in Nature Neuroscience signals a milestone, opening a new frontier to decode the brain’s spontaneous pain signaling through precision neuroimaging. While technical and translational hurdles remain, the pathway is illuminated toward personalized pain biomarkers that may one day fundamentally reshape diagnostics, patient care, and our understanding of the human brain in health and disease.
In conclusion, this work heralds a paradigm shift—ushering in an era where invisible chronic pain could be measured directly from the brain’s unique connectome. The fusion of intensive longitudinal neuroimaging with machine learning not only promises to deepen insights into chronic pain’s neural basis but also lays foundational stones for precision diagnostic tools and individualized therapies. As research continues to unravel the intricate tapestry of personalized brain pain networks, the vision of objective, brain-based pain assessment is coming into clearer focus—offering hope for millions who currently endure pain that remains frustratingly unseen and untreated.
Subject of Research: People
Article Title: Personalized brain decoding of spontaneous pain in individuals with chronic pain
News Publication Date: 26-Feb-2026
Web References: 10.1038/s41593-026-02221-3
Image Credits: Institute for Basic Science
Keywords: Chronic pain, Pain, Symptomatology, Diseases and disorders, Functional magnetic resonance imaging, Functional neuroimaging, Neuroimaging, Imaging, Research methods, Fibromyalgia, Longitudinal studies, Observational studies, Brain, Central nervous system, Nervous system, Anatomy, Organismal biology, Life sciences
